<DOC>
	<DOCNO>NCT00770432</DOCNO>
	<brief_summary>Randomized , placebo-controlled , double blind study . 203 subject enter study compare effect occasional constipation polyethylene glycol 3350 placebo . Subjects take one study treatments 7 day .</brief_summary>
	<brief_title>Study Comparing PEG 3350 Laxative Placebo Treatment Occasional Constipation ( Study CL2007-12 ) ( P08216 )</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Laxatives</mesh_term>
	<mesh_term>Polyethylene glycol 3350</mesh_term>
	<criteria>Subjects ( parents/guardians minor ) must demonstrate willingness participate ( children/wards participate ) study comply procedure sign write informed consent . Minor subject must provide write assent . Subjects must 17 year age old . Subjects must present current diagnosis untreated constipation 7 day less base signs/symptoms strain hard lumpy stool OR inability BM within 48 hour prior randomization trial . Subjects must OTC laxative user treatment occasional constipation ( define use nonprescription laxative treat least 3 episode constipation within last 12 month prior randomization ) . Subjects must willing use study drug 7 day direct , must agree record bowel movement ( frequency , consistency , etc . ) accurately consistently daily diary , make two clinic visit . Subjects must otherwise good health , determine physical exam medical history . Subjects must agree use product treat constipation course study . Subjects must agree use medication know cause constipation course study . Subjects must agree maintain similar diet week prior randomization end study . Female subject must either surgically sterile , 2 year postmenopausal , attest use acceptable method contraception ( include hormonal birth control , IUD , double barrier method , vasectomized partner ) . In female childbearing potential , urine pregnancy test ( HCG ) must negative Baseline . Subjects must able read diary English . Subjects currently doctor 's care treatment constipation . Subjects current constipation episode one week prior randomization . Subjects history chronic constipation due underlying cause ( inflammatory bowel disease , etc. ) . Subjects history 3 month constipation past year . Subjects severe abdominal pain predominant constipation symptom . Subjects previously use polyethylene glycol laxative . Subjects celiac disease know gluten sensitivity . Subjects history colorectal cancer , anal abscess , anal fistula , anal fissure , anal stenosis , gastric retention obstruction , bowel resection , rectocele , colostomy . Subjects know renal hepatic insufficiency . Subjects gastrointestinal bleed acute infection . Subjects history alcohol drug abuse . Subjects history psychiatric disorder . Subjects history significant ongoing medical problem , include kidney disease , schedule surgical procedure . Subjects currently take take within 7 day randomization concomitant medication cause constipation include example opiate , antidepressant , SSRI 's , antimotility agent , anticholinergic , etc . Subjects plan use laxatives treatment period study medication . Subjects , opinion investigator , include study reason , include inability follow study procedure . Subjects participate investigational clinical surgical , drug device study within past 30 day . Subjects pregnant lactating . Subjects allergic polyethylene glycol maltodextrin . Subjects employ immediate family member employ company manufacture laxative product .</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Human Experimentation</keyword>
</DOC>